Angelika Fuerst

Title: Angelika Fuerst: Innovator in Enzymatic Sensor Technology

Introduction

Angelika Fuerst is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of enzymatic sensors, particularly in the development of technologies for continuous analyte monitoring. With a total of 3 patents, her work has the potential to impact medical diagnostics and patient care.

Latest Patents

Fuerst's latest patents include innovative designs for measuring analyte concentrations under in-vivo conditions. One of her notable inventions is a diffusion layer for an enzymatic in-vivo sensor. This electrode system features immobilized enzyme molecules and a diffusion barrier that regulates the movement of analytes from surrounding body fluids to the enzyme molecules. Another significant patent is for a continuous analyte monitoring electrode with crosslinked enzyme. This enzymatic electrode is designed for continuous glucose monitoring, utilizing glucose oxidase as the enzyme molecule. It also includes an electrochemical sensor for measuring glucose concentrations in vivo.

Career Highlights

Throughout her career, Angelika Fuerst has worked with leading companies in the healthcare sector, including Roche Diabetes Care, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her expertise in sensor technology and contribute to advancements in diabetes management.

Collaborations

Fuerst has collaborated with notable professionals in her field, including Reinhold Mischler and Daniel Kammerer. These partnerships have fostered innovation and have been instrumental in the development of her patented technologies.

Conclusion

Angelika Fuerst's contributions to enzymatic sensor technology exemplify her dedication to improving healthcare solutions. Her innovative patents and collaborations highlight her role as a key figure in the advancement of medical diagnostics.